JP2022531251A5 - - Google Patents
Info
- Publication number
- JP2022531251A5 JP2022531251A5 JP2021564572A JP2021564572A JP2022531251A5 JP 2022531251 A5 JP2022531251 A5 JP 2022531251A5 JP 2021564572 A JP2021564572 A JP 2021564572A JP 2021564572 A JP2021564572 A JP 2021564572A JP 2022531251 A5 JP2022531251 A5 JP 2022531251A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962840434P | 2019-04-30 | 2019-04-30 | |
| US62/840,434 | 2019-04-30 | ||
| PCT/IB2020/053938 WO2020222108A1 (en) | 2019-04-30 | 2020-04-27 | Inhibitors of human immunodeficiency virus replication |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022531251A JP2022531251A (ja) | 2022-07-06 |
| JP2022531251A5 true JP2022531251A5 (https=) | 2023-04-26 |
| JPWO2020222108A5 JPWO2020222108A5 (https=) | 2023-04-26 |
| JP7545414B2 JP7545414B2 (ja) | 2024-09-04 |
Family
ID=70482731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564572A Active JP7545414B2 (ja) | 2019-04-30 | 2020-04-27 | ヒト免疫不全ウイルス複製阻害剤 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220211704A1 (https=) |
| EP (1) | EP3962603A1 (https=) |
| JP (1) | JP7545414B2 (https=) |
| WO (1) | WO2020222108A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021004593A (es) | 2018-10-24 | 2021-06-15 | Viiv Healthcare Uk No 5 Ltd | Inhibidores de la replicacion del virus de la inmunodeficiencia humana. |
| UY38982A (es) * | 2019-12-09 | 2021-06-30 | Viiv Healthcare Co | Composiciones farmacéuticas |
| US20250042926A1 (en) | 2023-05-31 | 2025-02-06 | Gilead Sciences, Inc. | Therapeutic compounds for hiv |
| AR132951A1 (es) | 2023-06-15 | 2025-08-13 | Viiv Healthcare Uk No 5 Ltd | Métodos e intermedios para preparar compuestos |
| US12594276B2 (en) | 2024-02-05 | 2026-04-07 | Viiv Healthcare Uk (No. 5) Limited | Inhibitors of human immunodeficiency virus replication |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102464654B (zh) | 2010-11-12 | 2016-01-13 | 上海泓博智源医药技术有限公司 | 抗病毒化合物 |
| EP2729448B1 (en) | 2011-07-06 | 2015-09-09 | Gilead Sciences, Inc. | Compounds for the treatment of hiv |
| CN102863512B (zh) | 2011-07-07 | 2016-04-20 | 上海泓博智源医药技术有限公司 | 抗病毒化合物 |
| CA2897268C (en) | 2013-01-09 | 2018-12-04 | Gilead Sciences, Inc. | Therapeutic compounds for the treatment of viral infections |
| TW201443037A (zh) | 2013-01-09 | 2014-11-16 | Gilead Sciences Inc | 治療用化合物 |
| CA2896244C (en) | 2013-01-09 | 2017-07-04 | Gilead Sciences, Inc. | 5-membered heteroaryls and their use as antiviral agents |
| TWI694071B (zh) | 2013-03-01 | 2020-05-21 | 美商基利科學股份有限公司 | 治療反轉錄病毒科(Retroviridae)病毒感染之治療性化合物 |
| WO2015130966A1 (en) | 2014-02-28 | 2015-09-03 | Gilead Sciences, Inc. | Antiviral agents |
| WO2015130964A1 (en) | 2014-02-28 | 2015-09-03 | Gilead Sciences, Inc. | Therapeutic compounds |
| PT3186239T (pt) | 2014-08-29 | 2019-01-10 | Gilead Sciences Inc | Agentes antirretrovirais |
| KR20230011471A (ko) | 2016-08-19 | 2023-01-20 | 길리애드 사이언시즈, 인코포레이티드 | Hiv 바이러스 감염의 예방적 또는 치유적 치료에 유용한 치료 화합물 |
| TW201906834A (zh) * | 2017-05-02 | 2019-02-16 | 英商Viiv醫療保健英國(No.5)有限公司 | 人類免疫不全病毒複製之抑制劑 |
| US20210393633A1 (en) * | 2018-10-25 | 2021-12-23 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
| US20210379071A1 (en) * | 2018-11-05 | 2021-12-09 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
-
2020
- 2020-04-27 EP EP20723545.8A patent/EP3962603A1/en not_active Withdrawn
- 2020-04-27 US US17/603,634 patent/US20220211704A1/en not_active Abandoned
- 2020-04-27 JP JP2021564572A patent/JP7545414B2/ja active Active
- 2020-04-27 WO PCT/IB2020/053938 patent/WO2020222108A1/en not_active Ceased